Baricitinib versus tocilizumab in critically ill COVID‐19 patients: A retrospective cohort study is a research paper published in Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: K08 GM147806
NHLBI NIH HHS
Grant: U01 HL123009
NIH HHS
National Institutes of Health
NIH HHS
FWCI
0.85
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals